Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | BMC Psychiatry

Fig. 2

From: Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

Fig. 2

Mean scores for depressive symptoms (MADRS-S) and sleep quality (Total PSQI) from baseline to post-treatment. Depressive symptoms were lower 12 weeks post-treatment. Total PSQI did not significantly change during DAA treatment. Abbreviations: MADRS-S, self-rating version of the Montgomery Åsberg Depression Rating Scale; PSQI, Pittsburgh Sleep Quality Index; 4WTx, 4 weeks of treatment; 8WTx, 8 weeks of treatment; EOT, end of treatment; 12WpostTx, twelve weeks post-treatment

Back to article page